International growth and the dividend support patience. But a tariff refund exceeded the entire quarterly increase in core operating profit, while North America needs more investment and the earnings outlook fell. Our three valuation routes cluster near $132–$134, supporting a rounded $135 anchor. At the observed price, the upside is too small for a fresh BUY with medium uncertainty. We would revisit near $115 if the business case remains intact.
Twelve-month valuation cases, explicitly judgmental
| Case | Probability | Value |
|---|---|---|
| Bear | 25% | 110 |
| Base | 50% | 135 |
| Bull | 25% | 160 |
| Scenario | Probability | 12-month value | vs $126.43 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 25% | $110.00 | −13% | North America remains weak; reinvestment fails to restore margins. | $8.00 prospective core EPS × 13.75 = $110. |
| Base | 50% | $135.00 | +7% | International growth offsets a slow domestic repair. | Three independent assumptions converge near $132–$134; rounded editorial anchor $135. |
| Bull | 25% | $160.00 | +27% | Volume and domestic profit recover together. | $8.80 prospective core EPS × 18.18 ≈ $160. |
| Weighted value = 25% × $110 + 50% × $135 + 25% × $160 = $135. This is not a guaranteed return or a probability inferred from option prices. | |||||
| Signpost | Now (Q3 2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| North America food margin | 21.2% core; −280 bps YoY | Decline narrows to ≤100 bps | Decline stays >200 bps | Q4 2026 results; date unconfirmed |
| PBNA organic growth | Slight decline; rounded 0% | At least +2% | Below 0% | Q4 2026 results |
| International growth | 8% organic | At least 6% with margin expansion | Below 4% | Q4 2026 results |
| Recurring operating profit | Refund-adjusted Q3 −0.9% computed | Positive growth excluding similar credits | Another negative quarter | Q4 2026 results |
| EPS guidance credibility | 2026 core CC +1% to +2% | Meets range without another cut | Below +1% | FY2026 results, expected early 2027 |
| Cash funding | 2025 issuer FCF $8.2bn; returns $8.638bn | FCF covers all cash returns | More than $1bn funding gap | FY2026 cash flow |
| Entry discipline | $126.43 observed; $135 fair value | $115 or lower with thesis intact | Value falls below observed price | Each quarterly review |
These are prospective decision thresholds. This is our first packet for this exact PepsiCo period; there is no prior packet scorecard to manufacture.
PepsiCo traded at $126.43 in the retained quote at 9:43 a.m. Central on October 8. That observation was about 2.18% above the previous close. It is an intraday observation, not the completed earnings-day return. The chart deliberately ends with the October 7 close; including a changing provider “close” during the session would mix two different measurements. A falling share price can improve valuation without proving that the operating problems are solved.
The company is a mature global food-and-beverage franchise, but the stock still represents a claim on future cash generation after reinvestment. Its indicated dividend yield is attractive relative to its own growth pace. That is a reason to examine funding carefully, rather than assuming the dividend makes the equity bond-like. The same affordability investments that can defend volumes may reduce the cash available for future dividend growth.
Prior earnings reactions have gone in both directions. The historical bars measure the release-day close against the preceding trading close for before-open prints. They are descriptive, not evidence that earnings alone caused each move. We retain the current release as an incomplete row in the dataset and do not substitute the morning move for its final reaction. Market and consensus data were collected during this research session; their underlying analyst judgments may still predate the guidance cut.
| Date | Close |
|---|---|
| 2025-07-01 | 135.26 |
| 2025-07-30 | 142.86 |
| 2025-08-27 | 147.64 |
| 2025-09-25 | 139.92 |
| 2025-10-23 | 151.51 |
| 2025-11-20 | 146.10 |
| 2025-12-19 | 148.16 |
| 2026-01-21 | 146.74 |
| 2026-02-19 | 164.59 |
| 2026-03-19 | 152.74 |
| 2026-04-17 | 157.67 |
| 2026-05-15 | 149.12 |
| 2026-06-15 | 146.25 |
| 2026-07-15 | 135.40 |
| 2026-08-12 | 138.70 |
| 2026-09-10 | 136.65 |
| Period | Value |
|---|---|
| 2024-10-08 | 1.92 |
| 2025-02-04 | −4.51 |
| 2025-04-24 | −4.89 |
| 2025-07-17 | 7.45 |
| 2025-10-09 | 4.23 |
| 2026-02-03 | 4.93 |
| 2026-04-16 | 2.28 |
| 2026-07-09 | −3.26 |
Revenue increased 5.6% to $25.274 billion. The issuer attributes the reported increase to 3.1% organic growth, a 1.7 percentage-point acquisition and divestiture contribution, and a 0.7-point currency benefit; rounding prevents these components from being a perfect additive bridge. Organic improvement is real, but buying revenue and translating foreign sales at favorable exchange rates are different from selling more product profitably.
Core EPS of $2.34 exceeded the retained provider consensus of $2.29, while sales exceeded its $24.953 billion estimate. Those are approximately 2.2% and 1.3% beats respectively, computed on comparable core EPS and revenue. A beat against a short-term estimate can coexist with a lower annual outlook. Here the updated guidance is more consequential than the narrow beat: full-year core constant-currency EPS growth is now 1%–2%, replacing the low end of the earlier 4%–6% range.
The core US-dollar EPS growth range fell to 2.5%–3.5% from the low end of 5%–7%. The tax assumption improved to approximately 21% from 22%, and expected currency assistance increased to about 1.5%. Those helps make the underlying domestic margin shortfall harder to dismiss. Revenue guidance of about 6% is stronger in reported terms, but organic guidance of about 3% sits within the earlier 2%–4% range. This is not an across-the-board demand collapse; it is a profitability conversion problem.
| Metric ($m except EPS) | Q3 2026 | Q3 2025 | Q2 2026 |
|---|---|---|---|
| Revenue | 25,274.00 | 23,937.00 | 24,181.00 |
| GAAP operating profit | 4,260.00 | 3,569.00 | 4,023.00 |
| Core operating profit | 4,277.00 | 4,137.00 | 4,067.00 |
| GAAP EPS | 2.23 | 1.90 | 2.18 |
| Core EPS | 2.34 | 2.29 | 2.20 |
| Primary issuer releases. Quarter lengths and seasonality matter; sequential comparisons are not annual growth. | |||
| Period | Value |
|---|---|
| Q3 2024 | 23,319.00 |
| Q4 2024 | 27,784.00 |
| Q1 2025 | 17,919.00 |
| Q2 2025 | 22,726.00 |
| Q3 2025 | 23,937.00 |
| Q4 2025 | 29,343.00 |
| Q1 2026 | 19,443.00 |
| Q2 2026 | 24,181.00 |
| Q3 2026 | 25,274.00 |
| Quarter | GAAP $m | Core $m |
|---|---|---|
| q3-2024 | 3,872 | 4,176 |
| q4-2024 | 2,250 | 3,462 |
| q1-2025 | 2,583 | 2,789 |
| q2-2025 | 1,789 | 3,911 |
| q3-2025 | 3,569 | 4,137 |
| q4-2025 | 3,557 | 4,075 |
| q1-2026 | 3,213 | 3,050 |
| q2-2026 | 4,023 | 4,067 |
| q3-2026 | 4,260 | 4,277 |
| 2026 guidance | Current | Previous |
|---|---|---|
| Organic revenue | About +3% | +2% to +4% |
| Net revenue | About +6% | +4% to +6% |
| Core CC EPS | +1% to +2% | Low end of +4% to +6% |
| Core USD EPS | +2.5% to +3.5% | Low end of +5% to +7% |
| Core tax rate | About 21% | About 22% |
| Cash returns | $8.9bn | $8.9bn |
The international engine deserves credit. Organic revenue grew 8%, core operating profit increased 16%, and core margin expanded 105 basis points. Management says international operations supplied 41% of year-to-date revenue and 45% of core segment operating profit. That profit share excludes corporate unallocated costs, so it is not interchangeable with a consolidated margin contribution. A geographically diverse brand portfolio can cushion a weak domestic cycle without making the domestic problem disappear.
Foods North America generated $6.504 billion of revenue, almost unchanged from $6.526 billion. Core operating profit fell to $1.382 billion from $1.570 billion. Management attributes the 280-basis-point margin decline to affordability investment, the lap of an asset-sale gain and higher advertising, partly offset by productivity and organic volume growth. Improving unit movement through cheaper packs or better value is useful, but investors need the next stage: stable pricing economics and profit conversion.
Beverages North America grew reported sales 5%, primarily because of acquisitions. Its organic revenue declined slightly, while the release rounds the headline rate to zero. The organic-volume revenue bridge shows a decline of 3%, versus a different physical-volume definition in the summary table. We preserve that distinction rather than blending the measures. Core profit increased 4%, but margin declined 15 basis points. Tariff refunds helped offset mix, volume and marketing pressure.
The international franchise business differs economically from owned bottling: concentrate shipments drive its recognized revenue, while retail case sales include activity outside consolidated revenue. Neither an impressive physical-volume statistic nor a brand’s retail-sales estimate should be dropped into the consolidated sales model. The packet uses reported segment dollars for valuation and treats operating volume as a directional signpost.
| Period | Value |
|---|---|
| PFNA | 6,504.00 |
| PBNA | 7,706.00 |
| IB Franchise | 1,401.00 |
| EMEA | 5,413.00 |
| LatAm Foods | 3,021.00 |
| Asia Pacific Foods | 1,229.00 |
| Period | Value |
|---|---|
| PFNA | 1,382.00 |
| PBNA | 1,012.00 |
| IB Franchise | 564.00 |
| EMEA | 940.00 |
| LatAm Foods | 626.00 |
| Asia Pacific Foods | 179.00 |
| Segment | 2025 $m | 2026 $m |
|---|---|---|
| PFNA | 1570.0 | 1382.0 |
| PBNA | 975.0 | 1012.0 |
| IB Franchise | 511.0 | 564.0 |
| EMEA | 808.0 | 940.0 |
| LatAm Foods | 523.0 | 626.0 |
| Asia Pacific Foods | 156.0 | 179.0 |
| Period | Value |
|---|---|
| PFNA | 0.50 |
| PBNA | −3.00 |
| IB Franchise | 5.50 |
| EMEA | 1.00 |
| LatAm Foods | 2.50 |
| Asia Pacific Foods | 11.00 |
Core operating profit was $4.277 billion versus $4.137 billion a year ago, a $140 million increase. The current quarter includes $178 million of tariff refunds. Removing that disclosed benefit produces $4.099 billion, about 0.9% below the prior-year core figure. This is a transparent sensitivity calculation, not an issuer-defined recurring-profit measure or a complete like-for-like adjustment. The prior year also contained an asset-sale benefit within North America foods, so this diagnostic cannot isolate every moving part. It does establish that the headline increase is smaller than a single identified current-period benefit.
GAAP operating profit was $4.260 billion. Starting from core, adding $79 million of commodity-mark gains, subtracting $192 million of restructuring charges and adding $96 million of acquisition-related net credits reconciles the total. The small net difference conceals large gross adjustments. Acquisition credits can improve reported income when expected contingent payments fall; they do not necessarily indicate better acquired-business performance.
Below operations, pension and retiree medical expense of $114 million and net interest and other expense of $242 million brought pretax income to $3.904 billion. Taxes of $834 million and minority income of $22 million left $3.048 billion attributable to PepsiCo. The minority claim is small; financing costs and business profitability dominate the investment question. Year-to-date reported growth is additionally flattered by the absence of large prior-year intangible impairments. Core profit offers a useful comparison, but it still includes the tariff benefit and ordinary reinvestment costs.
| Bridge item | $m |
|---|---|
| Core operating | 4277 |
| Commodity marks | 79 |
| Restructuring | −192 |
| Acquisition credits | 96 |
| GAAP operating | 4260 |
| Pension | −114 |
| Interest/other | −242 |
| Tax | −834 |
| Minorities | −22 |
| Parent income | 3048 |
| Item | $m |
|---|---|
| Core operating profit YoY change | 140 |
| Current tariff refund | 178 |
| Period | GAAP operating | Core operating | Parent income |
|---|---|---|---|
| Q3 2026 | 4260 | 4277 | 3048 |
| Q3 2025 | 3569 | 4137 | 2603 |
| YTD 2026 | 11496 | 11394 | 8356 |
| YTD 2025 | 7941 | 10837 | 5700 |
| USD millions; year-to-date spans 36 weeks. | |||
The quality question is broader than whether an adjustment is technically allowed. Restructuring is excluded from core income but requires cash. Commodity marks may reverse through future inventory costs. Acquisition-credit timing can benefit GAAP results without improving cash generation. Tariff refunds remain inside the current core result. These categories serve different purposes, and removing all of them mechanically would create another arbitrary profit definition.
Year-to-date stock compensation was $240 million, only 0.35% of revenue. Minority leakage is also modest. Those are favorable features. The larger cautions are the repeated cost-reduction program, the weaker North American margin trajectory and the gap between accounting earnings and cash after investment. Working-capital proxies are calculated using closing balances and the quarter’s sales or cost base. They are deliberately labeled proxies because averages, country mix and monthly international calendars would improve the precision.
Receivables increased from $11.506 billion at year-end to $13.623 billion, and inventory rose from $5.845 billion to $6.434 billion. Some increase is seasonal as the business moves through the year. The cash-flow statement confirms a material working-capital use, but a single end-point ratio cannot establish channel stuffing or excess inventory. We will look for cash conversion over the full fiscal year before treating the balance increase as a structural deterioration. Likewise, the provider’s statement classifications are cross-checked against primary statements: the packet retains actual GAAP operating profit rather than a vendor field that can omit a separately displayed impairment.
| Quarter | Receivable days | Inventory days |
|---|---|---|
| q3-2024 | 43.5 | 45.6 |
| q4-2024 | 41.7 | 45.1 |
| q1-2025 | 50.6 | 60.0 |
| q2-2025 | 45.8 | 52.9 |
| q3-2025 | 44.3 | 46.1 |
| q4-2025 | 43.9 | 47.7 |
| q1-2026 | 52.6 | 59.9 |
| q2-2026 | 46.9 | 51.1 |
| q3-2026 | 45.3 | 46.9 |
| Year | OCF | Capex | Simple FCF | Issuer FCF |
|---|---|---|---|---|
| 2023 | 13442.0 | 5518.0 | 7924.0 | 8122 |
| 2024 | 12507.0 | 5318.0 | 7189.0 | 7531 |
| 2025 | 12087.0 | 4415.0 | 7672.0 | 8200 |
The balance sheet contains $10.675 billion of cash and $488 million of short-term investments against $51.881 billion of short- and long-term debt. That is $40.718 billion of net debt on our liquid-assets definition. Investments in noncontrolled affiliates are not included as cash: their realization depends on market value, liquidity, strategic relationships and taxes. Debt is manageable for a diversified staple franchise, but it consumes part of the economic cushion that a gross-cash figure can imply.
Operating cash flow for the first 36 weeks was $7.950 billion. Subtracting $2.182 billion of capital expenditure gives $5.768 billion of simple free cash flow; adding $89 million of property sales gives the issuer’s $5.857 billion measure. Neither is cash available without obligations. Debt service, dividends and other commitments remain. Management continues to target at least 80% full-year free-cash-flow conversion against core net income, which is a different denominator from the GAAP comparison in our quality scorecard.
The annualized dividend is $5.92 per share. That implies a 4.68% yield at the observed quote, but future payments remain subject to board decisions. In 2025, dividends of $7.638 billion and buybacks of $1 billion exceeded issuer free cash flow of $8.2 billion by $438 million. This was not an enormous gap, but it means repurchases were not simply surplus internally generated cash. The 2026 cash-return plan stays at $8.9 billion. A stronger cash finish is therefore more valuable than an additional promise about cost savings. The newly authorized $10 billion repurchase program is capacity, not a guarantee that those shares will be bought immediately.
| Claim | $m |
|---|---|
| Market cap | 172,705.4 |
| Debt | 51881 |
| Cash + short investments | 11163 |
| Net debt | 40718 |
| Period | Value |
|---|---|
| Q3 2024 | 36,963.00 |
| Q4 2024 | 35,682.00 |
| Q1 2025 | 39,936.00 |
| Q2 2025 | 43,411.00 |
| Q3 2025 | 42,188.00 |
| Q4 2025 | 40,371.00 |
| Q1 2026 | 41,900.00 |
| Q2 2026 | 42,498.00 |
| Q3 2026 | 40,718.00 |
| Cash allocation ($m) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash | 13442.0 | 12507.0 | 12087.0 |
| Capital expenditure | 5518.0 | 5318.0 | 4415.0 |
| Stock compensation | 380.0 | 362.0 | 288.0 |
| Cash dividends | 6682.0 | 7229.0 | 7638.0 |
| Common repurchases | 1000.0 | 1000.0 | 1000.0 |
Our call is HOLD with conviction three out of five and medium uncertainty. The rounded fair-value anchor is $135, with an illustrative $110–$160 range. The stock has approximately 6.8% price upside to the anchor from the observed quote. That is not enough to call the margin of safety compelling while North America’s profit recovery remains unproven. A price near $115 would provide roughly 15% discount to the same anchor, provided the operating thesis had not deteriorated.
The earnings route starts with actual 2025 core EPS of $8.14 and management’s revised 3% midpoint growth, giving $8.3842. A judgmental sixteen-times multiple yields $134.15. This multiple recognizes durable brands and distribution, but stops short of paying a premium growth valuation for an earnings stream whose outlook has been reduced. The normalized EPS choice includes management’s current assumptions; it is not a claim that every adjustment will disappear.
The cash route uses a prospective $8.5 billion equity cash-flow base, after capital expenditure and with financing held broadly stable. It assumes 4% growth for five years, an 8% equity discount rate and 3% perpetual growth. The present value is $133.86 per diluted share using 1.367 billion shares. This is an equity cash-flow model, so subtracting debt again would double count financing. The $8.5 billion starting cash flow is our normalized assumption, above 2025 issuer free cash flow but below what a strong conversion of guided earnings could support. It is not a reported number.
The dividend route treats the current $5.92 annualized dividend as the first projected annual payment, with no initial step-up, and capitalizes it using a 7.5% required return and 3% long-run growth, producing $131.56. Because it excludes any separate repurchase value, this serves as an income-oriented cross-check. Both discount models are sensitive to the small difference between discount and terminal growth rates. Their convergence is conditional on those choices; it is not independent proof of precision.
At the observed price, the equity cash-flow model requires a starting normalized cash flow of about $8.03 billion under the same growth and discount assumptions. That is close to recent issuer free cash flow, so the market is not demanding a spectacular acceleration. It is still asking the business to sustain that cash generation while maintaining investment and its dividend. The reverse case explains why we are not bearish, while the small valuation discount explains why we are not upgrading to BUY.
$8.14 × 1.03 × 16 = $134.15.
$8.5bn normalized start; 4% five-year growth; 8% discount; 3% terminal growth; ÷ 1.367bn shares = $133.86.
$5.92 ÷ (7.5% − 3.0%) = $131.56.
| Core EPS | 14× | 16× | 18× | 20× |
|---|---|---|---|---|
| 8 | 112.00 | 128.00 | 144.00 | 160.00 |
| 8.4 | 117.60 | 134.40 | 151.20 | 168.00 |
| 8.8 | 123.20 | 140.80 | 158.40 | 176.00 |
| Cash model year | Projected equity cash flow $m |
|---|---|
| 1 | 8,840.00 |
| 2 | 9,193.60 |
| 3 | 9,561.34 |
| 4 | 9,943.80 |
| 5 | 10,341.55 |
| Terminal value uses year-five cash flow × 1.03 / (0.08 − 0.03). | |
The retained consensus rating is Hold: one strong buy, thirteen buys, thirty-one holds and one sell. Its average target is $145.25, with a $133–$176 range. We agree with the broad rating but use a lower $135 anchor. The difference reflects how much domestic recovery we are willing to capitalize before it appears in recurring profit and cash. A consensus target is an aggregation of different dates, horizons and methods, not a single freshly recalculated valuation.
The latest retained target-news item is RBC Capital’s October 6 reduction to $150 from $161. UBS was at $145 on October 2, Barclays at $133 on October 1 and Evercore ISI at $135 on September 30. These all precede the October 8 release. We therefore do not say analysts have already endorsed the revised earnings outlook. The provider’s 2026 EPS consensus near $8.54 is above the updated guidance-derived midpoint near $8.38; that gap is a revision risk, not proof of a future miss.
For 2027, the retained revenue estimate is approximately $101.58 billion and EPS $8.89, with different analyst counts for each metric. Farther-out estimates carry thinner coverage. Comparing these forecasts with management’s current-year targets is useful for identifying expectations, but treating the vendor’s annual net-income and EPS estimates as a fully reconciled GAAP forecast would overstate their consistency. We retain the original fields and counts so readers can evaluate the coverage themselves.
| Period | Value |
|---|---|
| Strong buy | 1.00 |
| Buy | 13.00 |
| Hold | 31.00 |
| Sell | 1.00 |
| Strong sell | 0.00 |
| Date | Firm | Target |
|---|---|---|
| 2026-10-06 | RBC Capital | $150 |
| 2026-10-02 | UBS | $145 |
| 2026-10-01 | Barclays | $133 |
| 2026-09-30 | Evercore ISI | $135 |
| 2026-09-29 | Jefferies | $138 |
| 2026-09-28 | Cowen & Co. | $133 |
| 2026-09-28 | Deutsche Bank | $138 |
| 2026-09-23 | BNP Paribas | $161 |
| FMP target news; listed observations precede Oct 8 results. | ||
| Basis | EPS |
|---|---|
| 2026 revised guide midpoint | 8.38 |
| 2026 consensus | 8.54 |
| 2027 consensus | 8.89 |
| Year | Revenue $bn | EBIT $bn | Net income $bn | EPS | Revenue/EPS analysts |
|---|---|---|---|---|---|
| 2026 | 98.91 | 15.54 | 11.70 | 8.54 | 16/12 |
| 2027 | 101.58 | 16.11 | 12.15 | 8.89 | 17/13 |
| 2028 | 104.88 | 16.92 | 12.80 | 9.37 | 15/6 |
Management’s language has become more explicit about the domestic repair taking longer than planned. We credit the international execution, organic-volume improvement and willingness to invest in affordability. We are less persuaded by savings programs until the savings become profit after the additional marketing and innovation expenditure required to sustain growth. A cost reduction that is fully reinvested may protect competitiveness without lifting the near-term earnings base.
Portfolio changes add promising products and exposure to functional hydration, zero sugar and newer snacking preferences. They also add integration costs, contingent consideration and the risk of paying for growth that could have been built more cheaply. The current release’s acquisition credits reinforce the need to distinguish purchase-accounting outcomes from customer demand. Neither a popular product nor a retail-sales headline guarantees an adequate return on invested capital.
Capital allocation remains shareholder-friendly in its intent, with an increased annualized dividend and planned repurchases. The test is whether internally generated cash funds those choices after maintaining plants, distribution and brands. We would ask management to quantify how much of the next margin improvement comes from sustainable operations versus asset sales, refunds or changes in acquisition liabilities. That reconciliation would be more useful than another broad productivity ambition.
| Promise or action | Evidence this quarter | Assessment |
|---|---|---|
| Accelerate organic growth | 3.1% consolidated; 8% international | Progress |
| Repair North America | Food core margin −280 bps | Not yet demonstrated |
| Deliver prior EPS range | 2026 core CC range reduced | Missed prior trajectory |
| Protect cash returns | $8.9bn plan unchanged | Requires full-year cash execution |
| Fund growth with savings | Further structural actions identified | Future benefit, not booked value |
The bull case is credible: leading brands, a broad distribution system and international growth can finance a domestic reset. Better value, innovation and functional categories may rebuild volumes. If domestic margin erosion slows while international growth persists, the stock could deserve a higher earnings multiple even before growth returns to its old pace. The dividend also returns cash while that process unfolds.
The bear case is that a low-growth consumer business now needs persistently more spending to defend its position. Lower-price packs may stabilize units but cap revenue per unit, and advertising can become a permanent cost rather than a temporary repair investment. Currency and acquired revenue can obscure that problem. A balance sheet with meaningful net debt and a large dividend commitment leaves less room for error if cash conversion weakens.
Our middle case gives value to the franchise without assuming a rapid domestic rebound. Medium uncertainty means we demand a visible price cushion or stronger recurring evidence before buying. The $110 bear scenario is illustrative, not a floor; a severe recession, execution failure or lasting loss of brand relevance could produce worse outcomes. Conversely, the $160 bull scenario requires both an earnings recovery and a higher multiple. It should not be described as a likely return simply because it appears in a chart.
| Risk | Likelihood | Impact | What we watch |
|---|---|---|---|
| Domestic pricing/volume trade-off | High | High | Organic growth plus core margin together |
| Commodity and tariff volatility | High | Medium | Refunds separated from recurring costs |
| FX translation reversal | Medium | Medium | Constant-currency versus reported growth |
| Acquisition return/integration | Medium | High | Organic growth, cash costs and write-downs |
| Dividend funding/leverage | Medium | High | Full-year FCF versus cash returns |
| Customer concentration | Medium | High | Walmart/affiliates were 14% of 2025 sales |
| Health preferences and competition | High | High | Portfolio relevance and unit share |
The next financial results are the principal checkpoint, but no exact date is asserted here without an issuer announcement. Provider calendars currently point to early February 2027; that estimate can change. In the meantime, announced cost actions, brand investments and cash distributions can inform the thesis, but they do not replace consolidated evidence. We would rather miss the first increment of a rebound than capitalize a margin recovery that remains a plan.
Our entry checkpoint is also conditional. A fall to $115 does not mechanically make the stock a BUY if the earnings base or cash generation has simultaneously deteriorated. Conversely, improved domestic margins and positive refund-adjusted profit growth could justify revisiting the fair-value assumptions even at a higher price. The point of the signposts is to connect an observable business result to a change in the decision. They are not a trading calendar or a promise to issue a recommendation on a preset date.
| Timing | Event | Decision relevance |
|---|---|---|
| Q4 2026 / coming months | Structural cost actions begin | Net savings after growth investment |
| FY2026 results; issuer date pending | Cash flow and updated outlook | Guidance credibility and dividend funding |
| Next quarter | North America margin/volume | Evidence of economic repair |
| Every quarter | International organic growth | Whether the offset remains durable |
| Ongoing | Price near $115 | Reassess with unchanged or better fundamentals |
The research uses nine original quarterly releases from Q3 2024 through Q3 2026, the latest quarterly and annual SEC filings, prepared management remarks and timestamped FMP market datasets. All derived ratios, bridges and valuation arithmetic are calculated in the saved data builder. Monetary statement figures are in US dollars; this packet does not introduce a currency conversion. Core measures are PepsiCo’s non-GAAP definitions and must be read with the retained reconciliations.
Historical quarterly tables retain the original releases rather than silently stitching together revised segment labels. The company moved from seven operating segments to six; the current year-on-year segment comparisons use the comparable figures supplied in the latest release. Q4 includes a longer reporting period than the other quarters, and international businesses use monthly calendars. Straight sequential comparisons can therefore mislead. Annual cash-flow totals are more suitable for funding analysis than multiplying one quarter by four.
Simple free cash flow means operating cash flow less capital expenditure. PepsiCo’s free cash flow adds proceeds from sales of property, plant and equipment. Net debt subtracts cash and short-term investments from reported debt; it does not subtract strategic equity holdings. EPS valuation uses diluted weighted-average shares where appropriate, while provider market capitalization uses its contemporaneous share basis. Working-capital days use period-end balances and are proxies. Scenario probabilities, multiples, discount rates, terminal growth and the normalized cash-flow base are editorial assumptions, not management forecasts.
The remaining uncertainty is ordinary forecasting uncertainty, not a claim that the public filings are incomplete. The exact release clock was not independently confirmed; the issuer had announced approximately 5 a.m. Central. SEC acceptance timestamps are retained separately and are not used as the market release time. Current price and consensus observations were collected after publication of the results, but the underlying analyst inputs may still reflect earlier views. A future revision to those inputs should be evaluated as new information, not retrospectively inserted into this dated decision.
| Quarter | $m revenue | $m GAAP op | $m core op | GAAP EPS | Core EPS |
|---|---|---|---|---|---|
| q3-2024 | 23,319 | 3,872 | 4,176 | 2.13 | 2.31 |
| q4-2024 | 27,784 | 2,250 | 3,462 | 1.11 | 1.96 |
| q1-2025 | 17,919 | 2,583 | 2,789 | 1.33 | 1.48 |
| q2-2025 | 22,726 | 1,789 | 3,911 | 0.92 | 2.12 |
| q3-2025 | 23,937 | 3,569 | 4,137 | 1.90 | 2.29 |
| q4-2025 | 29,343 | 3,557 | 4,075 | 1.85 | 2.26 |
| q1-2026 | 19,443 | 3,213 | 3,050 | 1.70 | 1.61 |
| q2-2026 | 24,181 | 4,023 | 4,067 | 2.18 | 2.20 |
| q3-2026 | 25,274 | 4,260 | 4,277 | 2.23 | 2.34 |
| Quarter | Pension | Interest/other | Tax | Minorities | Parent income |
|---|---|---|---|---|---|
| q3-2024 | 41 | −219 | 749 | 15 | 2,930 |
| q4-2024 | −177 | −264 | 275 | 11 | 1,523 |
| q1-2025 | 23 | −264 | 499 | 9 | 1,834 |
| q2-2025 | 42 | −260 | 292 | 16 | 1,263 |
| q3-2025 | 26 | −264 | 713 | 15 | 2,603 |
| q4-2025 | −224 | −333 | 445 | 15 | 2,540 |
| q1-2026 | 58 | −301 | 632 | 11 | 2,327 |
| q2-2026 | 59 | −230 | 848 | 23 | 2,981 |
| q3-2026 | −114 | −242 | 834 | 22 | 3,048 |
| USD millions; signed pension and interest rows follow primary presentation. | |||||
| Year | Employees | SBC $m | Dividends $m | Buybacks $m |
|---|---|---|---|---|
| 2023 | 318,000 | 380.0 | 6682.0 | 1000.0 |
| 2024 | 319,000 | 362.0 | 7229.0 | 1000.0 |
| 2025 | 306,000 | 288.0 | 7638.0 | 1000.0 |